BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30097064)

  • 1. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.
    Shroff R; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu S; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Ranchin B; Samaille C; Shenoy M; Sinha M; Smith C; Spasojevic B; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schaefer F; Schmitt CP
    BMC Nephrol; 2018 Aug; 19(1):199. PubMed ID: 30097064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
    Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
    Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
    Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
    BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Hemodiafiltration versus Conventional Hemodialysis in Children with ESKD: The HDF, Heart and Height Study.
    Shroff R; Smith C; Ranchin B; Bayazit AK; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Ağbaş A; Aitkenhead H; Anarat A; Aoun B; Aofolaju D; Bakkaloglu SA; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Deanfield J; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Samaille C; Shenoy M; Sinha MD; Spasojevic B; Stronach L; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schmitt CP; Schaefer F
    J Am Soc Nephrol; 2019 Apr; 30(4):678-691. PubMed ID: 30846560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients.
    Bellien J; Fréguin-Bouilland C; Joannidès R; Hanoy M; Rémy-Jouet I; Monteil C; Iacob M; Martin L; Renet S; Vendeville C; Godin M; Thuillez C; Le Roy F
    Nephrol Dial Transplant; 2014 Feb; 29(2):414-22. PubMed ID: 24235073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.
    Snauwaert E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Saoussen K; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Shroff R; Eloot S
    Nephrol Dial Transplant; 2020 Apr; 35(4):648-656. PubMed ID: 31361315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.
    Peters SA; Bots ML; Canaud B; Davenport A; Grooteman MP; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ;
    Nephrol Dial Transplant; 2016 Jun; 31(6):978-84. PubMed ID: 26492924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional and Anthropometric Indices in Children Receiving Haemodiafiltration vs Conventional Haemodialysis - The HDF, Heart and Height (3H) Study.
    Paglialonga F; Monzani A; Prodam F; Smith C; De Zan F; Canpolat N; Agbas A; Bayazit A; Anarat A; Bakkaloglu SA; Askiti V; Stefanidis CJ; Azukaitis K; Bulut IK; Borzych-Dużałka D; Duzova A; Habbig S; Krid S; Licht C; Litwin M; Obrycki L; Ranchin B; Samaille C; Shenoy M; Sinha MD; Spasojevic B; Vidal E; Yilmaz A; Fischbach M; Schaefer F; Schmitt CP; Edefonti A; Shroff R
    J Ren Nutr; 2023 Jan; 33(1):17-28. PubMed ID: 35870690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and methodology of the impact of HemoDiaFIlTration on physical activity and self-reported outcomes: a randomized controlled trial (HDFIT trial) in Brazil.
    Pecoits-Filho R; Larkin JW; Poli-de-Figueiredo CE; Cuvello Neto AL; Barra AB; Canhada S; de Campos LG; Woehl J; Gonçalves PB; Han H; de Moraes TP; Raimann JG; Canziani MEF;
    BMC Nephrol; 2019 Mar; 20(1):98. PubMed ID: 30894141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study.
    Molina P; Vizcaíno B; Molina MD; Beltrán S; González-Moya M; Mora A; Castro-Alonso C; Kanter J; Ávila AI; Górriz JL; Estañ N; Pallardó LM; Fouque D; Carrero JJ
    Nephrol Dial Transplant; 2018 Jul; 33(7):1223-1235. PubMed ID: 29370428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodiafiltration use in children: data from the Italian Pediatric Dialysis Registry.
    Paglialonga F; Vidal E; Pecoraro C; Guzzo I; Giordano M; Gianoglio B; Corrado C; Roperto R; Ratsch I; Luzio S; Murer L; Consolo S; Pieri G; Montini G; Edefonti A; Verrina E
    Pediatr Nephrol; 2019 Jun; 34(6):1057-1063. PubMed ID: 30612203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study.
    Kim TH; Kim SH; Kim TY; Park HY; Jung KS; Lee MH; Jhee JH; Lee JE; Choi HY; Park HC
    BMC Nephrol; 2019 Dec; 21(1):2. PubMed ID: 31892319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux hemodialysis in children.
    Ağbaş A; Canpolat N; Çalışkan S; Yılmaz A; Ekmekçi H; Mayes M; Aitkenhead H; Schaefer F; Sever L; Shroff R
    PLoS One; 2018; 13(6):e0198320. PubMed ID: 29912924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials.
    Vernooij RWM; Law W; Peters SAE; Canaud B; Davenport A; Grooteman MPC; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ; Bots ML;
    BMC Nephrol; 2021 Feb; 22(1):70. PubMed ID: 33632160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration.
    Jansz TT; Özyilmaz A; Grooteman MPC; Hoekstra T; Romijn M; Blankestijn PJ; Bots ML; van Jaarsveld BC
    BMJ Open; 2018 Mar; 8(3):e019900. PubMed ID: 29523566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study.
    Jean G; Hurot JM; Deleaval P; Mayor B; Lorriaux C
    BMC Nephrol; 2015 May; 16():70. PubMed ID: 25956949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.
    Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R
    Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of centre- and patient-related factors on uptake of haemodiafiltration in Australia and New Zealand: A cohort study using ANZDATA.
    Mac K; Hedley J; Kelly PJ; Lee VW; Agar JWM; Hawley CM; Johnson DW; See EJ; Polkinghorne KR; Rabindranath KS; Sud K; Webster AC
    Nephrology (Carlton); 2020 Jan; 25(1):63-72. PubMed ID: 30838737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CONVINCE in the context of existing evidence on haemodiafiltration.
    Vernooij RWM; Bots ML; Strippoli GFM; Canaud B; Cromm K; Woodward M; Blankestijn PJ;
    Nephrol Dial Transplant; 2022 May; 37(6):1006-1013. PubMed ID: 35098994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.